▟ Vinebot intrinsic value, daily

← back

MS Morgan Stanley

capital_markets · valued with opus medium conviction · deep-dived 2026-11-16

SELL
Intrinsic value$96.06
Price (at call)$190.65
Margin of safety -49.6%
vs market (rating basis) -26.7%

Wealth mix lifts the ROE floor, but 2.9x book still capitalizes peak capital-markets returns.

The story

Morgan Stanley is now a wealth-and-asset-management franchise wrapped around a top-tier institutional securities business. Fee-based wealth assets supply stable, capital-light earnings, and that mix has pushed through-cycle returns structurally higher. The current ~20% ROE, however, rests on peak conditions: record trading, a strong M&A/ECM rebound, and elevated asset levels. Capital is strong (CET1 well above requirements), but the institutional half stays cyclical and market-sensitive, and the stock at ~2.9x book prices peak returns as permanent.

I raised normalized ROE only modestly, from 16% to 16.5%. ROE has now held near 20% for several more quarters, and wealth-management mix keeps growing, which supports a higher through-cycle floor. I still cap it well below trailing because about 40% of earnings are cyclical trading and banking, and reported book includes preferred equity. Book growth, beta, and failure risk are unchanged, because buybacks and dividends take most of the retained earnings and leverage plus market exposure justify an above-anchor beta.

Value drivers

Return on equity (normalized)16.5%
Book-value growth (Y1)6.0%
Terminal book growth4.0%
Beta1.20
Failure probability1.0%
Cost of equity10.6%

Valuation bridge

PV of excess returns31.21B
PV of terminal excess18.56B
Equity value150.14B
÷ shares → per share$96.06

Projected excess returns on equity

YrBook equityROEExcess returnPV
1101.88B 16.5%6.06B 5.48B
2107.99B 16.1%5.95B 4.87B
3114.23B 15.6%5.79B 4.29B
4120.58B 15.2%5.58B 3.74B
5127.01B 14.7%5.32B 3.22B
6133.50B 14.3%5.01B 2.74B
7140.03B 13.9%4.64B 2.30B
8146.57B 13.4%4.22B 1.89B
9153.08B 13.0%3.73B 1.51B
10159.54B 12.6%3.19B 1.17B

Key risks

  • Capital-markets downturn compresses trading and investment-banking revenue and drags ROE back toward 10-13%
  • Equity bear market cuts fee-based wealth revenue linked to client assets and slows net new asset flows
  • Regulatory capital changes (Basel endgame, SCB, G-SIB surcharge) restrict buybacks or raise required equity

Catalysts

  • Delivering 20%+ ROTCE through a softer market quarter would validate a higher normalized ROE
  • Final Basel III endgame relief releasing excess capital for larger buybacks

History

DatePriceIntrinsicMoSRating
2026-11-16$190.65 $96.06 -49.6% SELL
2026-10-21$180.40 $94.53 -47.6% SELL
2026-09-25$196.32 $92.96 -52.6% HOLD
2026-09-01$213.32 $94.34 -55.8% SELL
2026-08-06$218.27 $93.08 -57.4% SELL
2026-07-10$222.13 $90.48 -59.3% SELL
2026-06-23$226.03 $89.55 -60.4% SELL